Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2021-11-09 Declaration of Voting R…
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
شركة الخليج للصناعات الدوائية نتائج اجتماع مجلس الإدارة 10/11/2021 الساعة 10:00
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is in Arabic and the title translates to 'Disclosure of Board of Directors Meeting Results'. It includes details such as the date and time of the meeting, attendance percentage, approval of minutes from a previous meeting, approval of financial results for the third quarter of 2021, and other business matters. This indicates it is an official announcement of the results of a board meeting rather than the full financial report itself. The document length is short (880 characters), and it primarily reports decisions and approvals made during the meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder or board votes at meetings.
2021-11-09 Arabic
Gulf Pharmaceutical Industries Board Meeting Results held on 10/11/2021 at 10:00
Board/Management Information Classification · 95% confidence The document is a disclosure of the results of a Board of Directors meeting held on November 10, 2021. It includes approval of the minutes from a previous meeting and approval of the 3rd Quarter 2021 unaudited financial results. The document is short (829 characters) and primarily reports decisions made in the board meeting rather than providing detailed financial statements or analysis. It does not contain the full quarterly report but rather a summary of board resolutions. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2021-11-09 English
وقف التداول موقتا علي أسهم شركة شركة الخليج للصناعات الدوائية
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific regulatory article related to the listing of securities on ADX (Abu Dhabi Securities Exchange) and details the suspension timing and instructions for execution. There is no financial data, report content, or management discussion. The document is an official regulatory announcement about trading suspension, not a financial report or meeting material. Given the nature of the content, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-11-08 Arabic
Temporary suspension of trading on the shares of Gulf Pharmaceutical Industries
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific regulatory article related to listing regulations on ADX (Abu Dhabi Securities Exchange) and details the suspension timing due to a board meeting. The document is short (1826 characters) and is an official announcement about trading suspension, not a financial report, earnings release, or management discussion. It does not contain financial data or results but is a regulatory announcement related to trading status. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-11-08 English
شركة الخليج للصناعات الدوائية اعلان اجتماع مجلس الإدارة بتاريخ 10/11/2021 الساعة 10:00
Board/Management Information Classification · 95% confidence The document is in Arabic and references a meeting of the Board of Directors held on November 10, 2021, with agenda items including approval of the minutes of a previous Board meeting and approval of financial results for the third quarter of 2021. The content focuses on the agenda and minutes of a Board meeting rather than full financial statements or detailed financial analysis. The document length is short (672 characters), and it appears to be materials related to a Board meeting rather than a full report or announcement of voting results. Therefore, the document best fits the category of Board/Management Information (MANG), which covers announcements related to Board meetings and management matters.
2021-11-06 Arabic
Gulf Pharmaceutical Industries Announcement of Board Meeting to be held on 10/11/2021 at 10:00
Board/Management Information Classification · 95% confidence The document is a disclosure of a board meeting held in November 2021, including agenda items such as approval of minutes and approval of unaudited financial results for the 3rd quarter of 2021, as well as business updates. It is not a full financial report but rather a summary of board meeting activities and decisions. This fits the category of Board/Management Information (MANG), which covers announcements related to board meetings and management matters. The document length is short and does not contain detailed financial statements or analysis, so it is not an Interim/Quarterly Report (IR) or Annual Report (10-K).
2021-11-06 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.